CareDx
CDNA
#5976
Rank
HK$8.33 B
Marketcap
HK$161.38
Share price
3.20%
Change (1 day)
16.69%
Change (1 year)

P/E ratio for CareDx (CDNA)

P/E ratio as of May 2026 (TTM): -127

According to CareDx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -126.625. At the end of 2025 the company had a P/E ratio of -47.1.

P/E ratio history for CareDx from 2014 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-47.1-308.99%
202422.5
2022-7.92-89.72%
2021-77.1-55.31%
2020-172315.86%
2019-41.5119.45%
2018-18.9469.13%
2017-3.32204.74%
2016-1.09-80.42%
2015-5.57-106.83%
201481.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
T2 Biosystems
TTOO
-0.0001-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
-4.05-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Invitae
NVTA
-0.0060-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.